Cogent Biosciences, Inc. — Director's Dealing 2019

Feb 11, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Unum Therapeutics Inc. (UMRX)
CIK: 0001622229
Period of Report: 2019-01-31

Reporting Person: Green John L. (See Remarks)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$14.36	2028-07-25	Common Stock (9235)		Direct

Footnotes

F1: 25% of the shares vest on July 25, 2019, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer.